11/14/2024
6:50 PM | Fate Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
10/25/2024
8:37 PM | Boxer Capital Management, LLC (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G/A | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G/A | |
08/30/2024
3:21 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:01 PM | Fate Therapeutics (Issuer)
Xu Yuan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
9:34 AM | Fate Therapeutics (Subject)
Xu Yuan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
4:59 PM | Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
07/31/2024
5:00 PM | Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
5:01 PM | Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
5:05 PM | Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:03 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
5:19 PM | Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
5:20 PM | Fate Therapeutics (Issuer)
Lee Michael Stewart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:35 PM | Fate Therapeutics (Issuer)
RASTETTER WILLIAM H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:30 PM | Fate Therapeutics (Issuer)
Jooss Karin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
4:05 PM | Fate Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/10/2024
3:31 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
4:26 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
4:24 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
8:01 AM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
11:15 PM | Fate Therapeutics (Filer)
| Form EFFECT | |
04/26/2024
3:16 PM | Fate Therapeutics (Filer)
| Form ARS | |
03/25/2024
8:30 PM | Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:15 PM | Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13D/A | |
03/20/2024
4:30 PM | Fate Therapeutics (Filer)
| Form 424B5 | |
03/04/2024
12:29 PM | Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
5:06 PM | Boxer Capital, LLC (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G | |
02/09/2024
5:19 PM | Capital World Investors (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
3:01 PM | Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
12:44 PM | Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024
12:46 PM | Fate Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/10/2024
3:29 PM | Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:29 PM | Fate Therapeutics (Issuer)
Wolchko J Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:30 PM | Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:30 PM | Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:35 PM | Fate Therapeutics (Subject)
Valamehr Bahram (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:36 PM | Fate Therapeutics (Subject)
TAHL CINDY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:36 PM | Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:39 PM | Fate Therapeutics (Subject)
Wolchko J Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
11:17 AM | Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Let’s be blunt (Ad) Let me be blunt with you for just a second…
You may think you know when and why stocks move, but you’re wrong…
Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight.
But once you’ve cracked this code…
It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!  Check out the $100 Challenge now |
12/28/2023
8:30 PM | Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:53 PM | Fate Therapeutics (Subject)
| Form SC 13D/A | |
12/28/2023
3:53 PM | Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13D/A | |
12/18/2023
10:40 AM | Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2023
11:15 PM | Fate Therapeutics (Filer)
| Form EFFECT | |
